维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Geling O"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis Systematic reevaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
2	Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment 显示文摘	Deplanque D Gele P Petrault O	2003	J Neurosci2003，23，15：	1
3	Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance 显示文摘	Bastide M Gele P Petrault O	2003	J Cereb Blood Flow Metab2003，23，4：	1
4	Involvement of thrombolysis in recombinant tissue plasminogen activator - induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function 显示文摘	Gautier S Petrault O Gele P	2003	Stroke2003，34，12：	1
5	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical ev- idence and drug cost implications 显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
6	Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance显示文摘	Bastide M Gele P Petrault O	2003	J Cereb Blood Flow Metab2003，23，2：	1
7	Peroxisome prolife- rator-activated receptor-or activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment 显示文摘	Deplanque D Gele P Petrauh O	2003	J Neurosci2003，23，15：	1
8	Should 5-hydroxytryptamine 3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Sys- tematic re-evaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler H	2005	J Clin Oncol2005，23，6：	1
9	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic reevaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Chn Oncol2005，23，6：	1
10	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis systematic re-evaluation of clinical evidence and drug cost implications 显示文摘	Geling O Eichler H G	2005	J Clin Oncol2005，23，6：	1
11	Should 5-hyroxytryptamine-3 receptor antagonists be administered beyond 24 hours 'after chemotherapy to prevent delayed mesis? Systematic re-evaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
12	Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treat- ment显示文摘	DEPEANQUE D GELE P PETRAULT O	2003	J Neurosci2003，23，15：	1
13	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
14	A risk assessment tool (OsteoRisk) for identifying latin American women with osteoporosis显示文摘	Dr. Shuvayu S. Sen PhD Vincent P. Rives PharmD Osvaldo D. Messina MD Jorge Morales-Torres MD Gregorio Riera MD Juan M. Angulo-Solimano MD Jo?o F. M. Neto MD Alberto Frisoli MD Ricardo C. Sáenz MD Olga Geling PhD Philip D. Ross PhD	2005	Journal of General Internal Medicine2005，，3：	1
15	Should 5-hydroxyptamine-3 receptor antagonistsbeadministered beyond 24 hours after chemotherapy to prevent delayed emesis- Systematicre-evaluation of clinical evidence and drug cost implicanions显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
16	Should 5-hydroxytryptamine-3 re- ceptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-e- valuation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
17	Dynamic modelling of water demand,water availability and adaptation strategies for power plants to global change显示文摘	Koch H V(o)gele S		0，，7：	1
18	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Clin Oncol2005，23，6：	1
19	Should 5-hydro- xytryptamine-3 receptor an-tagonists be administered beyoud 24 hours atier chemo- therapy to prevent delayed emesis syste- matic reevaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Clin On- col2005，23，6：	1
20	Effect of a conventional energy-restricted modified diet with or without meal replacement on weight loss and cardiometabolic risk profile in overweight women显示文摘	METZER CE FOLBERTH-V(O)GELE A BITTERLICH N		0，，01：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示